High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort

Open Access

Peer-reviewed

Research Article

Alan T. Clarke ,

* E-mail: aclarke1972@gmail.com

Affiliation Dept. of Gastroenterology, Queen Elizabeth University Hospital, Glasgow, United Kingdom
⨯
Paul C. D. Johnson,

Affiliations Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom
⨯
Gillian C. Hall,

Affiliation Grimsdyke House London, London, United Kingdom
⨯
Ian Ford,

Affiliation Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom
⨯
Peter R. Mills

Affiliation Dept. of Gastroenterology, Gartnavel General Hospital, Glasgow, United Kingdom
⨯

Reader Comments (0)

Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Liver diseases
Is the Subject Area "Liver diseases" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Liver transplantation
Is the Subject Area "Liver transplantation" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.